| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.14 | 0.6 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.6 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.18 | 0.6 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.6 |